Betacorten

/ Trima

See prescribing information for full details.

Corticosteroid-responsive inflammation, pruritis, allergic conditions of skin.

Known hypersensitivity, fungal infections, tuberculosis of the skin, vaccinia, varicella, and herpes simplex. Should not be applied in the external auditory canal of patients with perforated eardrum. Not intended for ophthalmic use.

Pregnancy and lactation, pediatrics. If sensitization or irritation occurs, discontinue use. In the presence of an infection, the use of an appropriate antifungal or antibacterial agent should be instituted. If a favorable response is not obtained, the use of this preparation should be temporarily discontinued. If extensive areas are treated or if the occlusive technique is used, the possibility exists of increased systemic absorption. Systemic absorption of topical corticosteroids has produced reversible HPA axis suppression, manifestations of Cushing’s syndrome, hyperglycemia and glucosuria in some patients. Such patients should be periodically evaluated for evidence of HPA axis suppression. Application to children should be limited to the least amount compatible with an effective therapeutic regimen.

Burning, itching, irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, maceration of the skin, secondary infection, skin atrophy, striae, and miliaria.

Phenytoin, barbiturates, carbamazepine, aminoglutethimide, rifampicin. Thiazide and loop diuretics, cardiac glycosides, acetazolamide. Oral hypoglycemics, insulin. Antihypertensives, anabolic steroids, ophthalmic idoxuridine, NSAID.